Aflibercept biosimilar (Momenta/Mylan) | Interleukin Related interleukin-related.com

Product Name :
Aflibercept biosimilar (Momenta/Mylan)

Search keywords :
PLGF

drugId :
null

Target Vo:
Placental Growth Factor

Target Vo Short Name :
PGF

Moa_Name:
Placental Growth Factor inhibitors

First Approval Country :
EU

First Approval Date Filter:
2023

Origin Company_Name :
Mylan Nv

Active Company_Name :
Biocon Biologics Inc

Active Indication_Name:
Macular Edema

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Sutimlimab Epigenetic Reader Domain
Phospho-JNK1 (Thr183/Tyr185) Rabbit mAb Data Sheet
BMAL1 Antibody: BMAL1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to BMAL1. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts